Identification of an AAA ATPase VPS4B-dependent pathway that modulates epidermal growth factor receptor abundance and

H Helen Lin1, Xu Li, Jo-Lin Chen

  • 1Department of Molecular Pharmacology, Beckman Research Institute, City of Hope, Duarte, California, USA.

Insights

Hypoxia downregulates VPS4B in solid tumors, promoting breast cancer growth and drug resistance. This downregulation leads to increased epidermal growth factor receptor (EGFR) levels, driving tumor progression.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • VPS4B (ATPase associated with various cellular activities) is crucial for vesicular trafficking and autophagosome maturation.
  • Hypoxia is prevalent in solid tumors and linked to poor treatment outcomes.
  • Understanding VPS4B's role in tumor progression under hypoxia is critical.

Purpose of the Study:

  • To investigate the effect of hypoxia on VPS4B expression in breast cancer.
  • To elucidate the mechanism by which VPS4B influences cancer cell growth and drug resistance.
  • To determine the relationship between VPS4B, epidermal growth factor receptor (EGFR), and tumor progression.

Main Methods:

  • Assessing VPS4B downregulation induced by hypoxia using 3D spheroid cultures.
  • Utilizing short hairpin RNA (sh-VPS4B) and dominant-negative VPS4B(E235Q) to inhibit VPS4B function.
  • Analyzing EGFR activation, accumulation, and signaling pathways (FOS/JUN, AP-1) in VPS4B-compromised cells.
  • Correlating VPS4B expression with EGFR abundance in human breast tumors.

Main Results:

  • Hypoxia induces VPS4B downregulation via the ubiquitin-proteasome system.
  • VPS4B inhibition promotes anchorage-independent breast cancer cell growth and resistance to gefitinib, U0126, and genotoxicity.
  • Compromised VPS4B leads to EGFR hyperactivation, increased accumulation, and altered compartmentalization.
  • VPS4B depletion enhances FOS/JUN induction and AP-1 activation but does not affect EGFRvIII.
  • An inverse correlation exists between VPS4B expression and EGFR abundance in breast tumors, with lower VPS4B in high-grade/recurrent cancers.

Conclusions:

  • VPS4B downregulation, potentially induced by chronic hypoxia, plays a significant role in breast cancer progression.
  • This downregulation offers a nongenomic mechanism for EGFR overproduction in human breast cancer.
  • Targeting VPS4B or counteracting its hypoxia-induced degradation may represent a therapeutic strategy.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
ATP Driven Pumps III: V-type Pumps01:30

ATP Driven Pumps III: V-type Pumps

V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...